Bradykinin

Pro-inflammatory peptide, acting through G-protein-coupled receptors. Endogenous bradykinin receptor agonist that displays selectivity for B2 over B1 receptors. Endogenously formed following pathophysiological stimuli such as inflammation, tissue damage or anoxia. Activator of endothelial nitric oxide synthase (eNOS; NOS III). Reduces blood pressure by inducing the release of prostacyclin, nitric oxide and endothelium-derived hyperpolarizing factor. Plays an important role in the regulation of fluid and electrolyte balance, non-vascular smooth muscle contraction, vasodilation and capillary permeability.

Price Not Available 25 mg Bradykinin Supplier Page
Catalog Number AG-CP3-0025-M025
Alternative Name(s) H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH . TFA
Research Area Autophagy, Biochemicals, Cancer, Cell Death, Immunology, Inflammation, Metabolism, Neurobiology, Neurodegenerative Disease
Molecular Formula C50H73N15O11 . C2HF3O2
CAS# 121283-65-6 | 58-82-2 (free base)
Purity >97%
Inchi InChI=1S/C50H73N15O11.C2HF3O2/c51-32(16-7-21-56-49(52)53)45(72)65-25-11-20-39(65)47(74)64-24-9-18-37(64)43(70)58-28-40(67)59-34(26-30-12-3-1-4-13-30)41(68)62-36(29-66)46(73)63-23-10-19-38(63)44(71)61-35(27-31-14-5-2-6-15-31)42(69)60-33(48(75)76)17-8-22-57-50(54)55;3-2(4,5)1(6)7/h1-6,12-15,32-39,66H,7-11,16-29,51H2,(H,58,70)(H,59,67)(H,60,69)(H,61,71)(H,62,68)(H,75,76)(H4,52,53,56)(H4,54,55,57);(H,6,7)/t32-,33-,34-,35-,36-,37-,38-,39-;/m0./s1
Inchi Key WTRZIOCXFWDHEM-MIEKKPBHSA-N
SMILES [O-]C(=O)C(F)(F)F.N[C@@H](CCCNC([NH3+])=N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Size 25 mg
Supplier Page http://www.adipogen.com/ag-cp3-0025/bradykinin.html